ABSTRACT
OBJECTIVE: To assess the effectiveness of solution-focused therapy (SFT) on fatigue and quality of life (QoL) in patients with fatigued inflammatory bowel disease (IBD). DESIGN: Randomised controlled trial in two Dutch hospitals. Patients with IBD with quiescent IBD and with a Checklist Individual Strength--Fatigue (CIS--fatigue) score of ≥ 35 were enrolled. Patients were 1:1 randomised to receive SFT or care as usual (CAU) for 3 months. Patients were followed for a further 6 months after the SFT. Primary endpoint was defined as changes in fatigue and QoL during follow-up. Secondary endpoints included change in anxiety and depression, medication use, side effects to medication, disease activity, laboratory parameters (C-reactive protein, leucocytes and haemoglobin) and sleep quality. RESULTS: Ninety-eight patients were included, of whom 63% were women, mean age was 40.1 years. After the SFT course, 17 (39%) patients in the SFT group had a CIS-fatigue score below 35 compared with eight (18%) of patients in the CAU group (p=0.03). The SFT group also showed a greater reduction in fatigue across the first 6 months compared with the CAU group (CIS-fatigue: p=<0.001 and CIS-total: p=0.001). SFT was associated with a significant higher mean IBD questionnaire change at 3 months (p=0.020). At 9 months, no significant differences between the two groups were observed. CONCLUSIONS: SFT has a significant beneficial effect on the severity of fatigue and QoL in patients with quiescent IBD. However, this effect diminished during follow-up.
Subject(s)
Fatigue/therapy , Inflammatory Bowel Diseases/psychology , Psychotherapy, Group , Quality of Life , Adult , Anxiety/etiology , Anxiety/psychology , C-Reactive Protein/metabolism , Depression/etiology , Depression/psychology , Fatigue/etiology , Fatigue/psychology , Female , Gastrointestinal Agents/adverse effects , Hemoglobins/metabolism , Humans , Inflammatory Bowel Diseases/drug therapy , Leukocyte Count , Male , Middle Aged , Psychiatric Status Rating Scales , Quality of Life/psychology , Severity of Illness Index , SleepSubject(s)
Colon/pathology , Colonic Diseases/diagnosis , Digestive System Fistula/diagnosis , Gallbladder Diseases/diagnosis , Gallbladder/pathology , Aged , Colonic Diseases/pathology , Digestive System Fistula/pathology , Gallbladder Diseases/pathology , Humans , Male , Radiography, Abdominal , Tomography, X-Ray ComputedABSTRACT
Until recently, hepatitis E was considered to be an infectious disease that resolved without any long-term complications. We describe a 47-year-old woman who presented with a decompensated liver cirrhosis with ascites and peripheral oedema, 14 years after successful kidney transplantation. A previous extensive analysis of persistent liver enzyme disorders had not yielded a diagnosis, whereas now laboratory tests showed slightly abnormal liver results. The CT scan revealed ascites with signs of a decompensated liver cirrhosis. A liver biopsy revealed an active micronodular cirrhosis. Serological tests into the usual infectious causes of hepatitis provided no conclusive evidence but PCR on hepatitis E virus RNA and ELISA on virus-specific IgM and IgG were both positive on 2 occasions, suggestive for an active hepatitis E infection, the probable cause of the cirrhosis. The patient died several weeks later as a consequence of hepatic and renal failure. Hepatitis E was previously regarded as a travel-related disease from endemic areas. However, it is increasingly being observed in Western countries as well, where infection can take place due to intensive contact with animals and the consumption of infected meat.
Subject(s)
Hepatitis E/complications , Kidney Transplantation , Liver Cirrhosis/virology , Liver/pathology , Biopsy , Fatal Outcome , Female , Hepatitis E/diagnosis , Humans , Liver Cirrhosis/diagnosis , Middle AgedABSTRACT
PURPOSE: This study was designed to assess the relationship of anal endosonography and manometry to anorectal complaints in the evaluation of females a long time after vaginal delivery complicated by anal sphincter damage. METHODS: Thirty-four patients with anal sphincter damage after delivery, 22 with and 12 without anorectal complaints, and 12 controls without anorectal complaints underwent anal endosonography, manometry, and rectal sensitivity testing. Complaints were assessed by questionnaire, with a median follow-up of 19 years. RESULTS: Median maximum anal resting pressures were significantly lower in patients with anal sphincter damage with complaints (31 mmHg) than in controls (52 mmHg; P < 0.001). Median maximum anal squeeze pressures were significantly lower in patients with (55 mmHg) and without (69 mmHg) complaints than in controls (112 mmHg; P < 0.001 for both). Maximum anal resting pressures were significantly lower in patients with anorectal complaints after anal sphincter damage than in patients without complaints (P = 0.02). Results of anal manometry showed a large overlap between all groups. Rectal sensitivity showed no significant differences between the three groups. Persisting sphincter defects, shown by anal endosonography, were significantly more present in patients with anal sphincter damage after delivery with (86 percent) and without (67 percent) complaints than in controls (8 percent; P < 0.001 and P < 0.01, respectively). No differences in the number of echocardiographically proven sphincter defects were found between patients with or without anorectal complaints after anal sphincter damage CONCLUSIONS: Echographically proven sphincter defects are strongly associated with a history of anal sphincter damage during delivery. Sphincter defects are present in the majority of patients with anorectal complaints. Anal manometry provides little additional therapeutic information when performed after anal endosonography in patients with anorectal complaints after anal sphincter damage during delivery.
